Alnylam Pharmaceuticals (ALNY) Q2 2025 Earnings

May 1Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-1.07
-0.75
-0.44
-0.13

Details

Expected EPS
-0.890018
Actual EPS
-0.44
Surprise EPS
0.45
Surprise Percent
+50.56%

Description

⁨Alnylam Pharmaceuticals⁩ (⁦ALNY⁩) has reported earnings of ⁦-0.44⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts